| Advancing Pluripotent Stem Cell Culture: It Is a Matter of Setting the Standard. | |
| | |
MedLine Citation:
|
PMID: 23330735 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Human pluripotent stem cells (hPSCs), defined by their ability to proliferate indefinitely and the capacity to differentiate into all tissue cell types of the adult, represent a platform for the realization of breakthrough technologies for industrial and regenerative medicine applications. We have witnessed tremendous developments over the last decade related to methods for establishment, maintenance, differentiation, and applications of hPSCs and their derivatives. Despite all progress made in the hPSC field, there are still fundamental issues yet to be resolved. For example, our understanding of the pluripotent state remains limited, which in turn may have substantial consequences on how we interpret and communicate scientific data concerning hPSCs. This brief commentary aims to highlight recent important findings that demonstrate additional levels of complexity to the current assessment of pluripotent stem cell cultures. In addition, these data may help to provide some explanations for the challenges in reproducing hPSC differentiation protocols across laboratories. |
| | |
Authors:
|
Peter Sartipy |
Related Documents
:
|
23772025 - Paraoxonase-1 suppresses experimental colitis via the inhibition of ifn-γ production f... 23584435 - Comparable efficacy and lower cost of pbsc mobilization with intermediate-dose cyclopho... 23344265 - B-cell maturation antigen is a promising target for adoptive t-cell therapy of multiple... 23434825 - Characterization of the adipocyte cellular lineage in vivo. 22763855 - Cancer-stimulated mesenchymal stem cells create a carcinoma stem-cell niche via prostag... 17056765 - Continued evolution of hiv-1 circulating in blood monocytes with antiretroviral therapy... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-18 |
Journal Detail:
|
Title: Stem cells and development Volume: - ISSN: 1557-8534 ISO Abbreviation: Stem Cells Dev. Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101197107 Medline TA: Stem Cells Dev Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Cellectis Stem Cells , Cellartis AB, Göteborg, Sweden . |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Defining Vascular Stem Cells.
Next Document: The Globoseries Glycosphingolipid SSEA-4 Is a Marker of Bone Marrow-Derived Clonal Multipotent Strom...